Kohjin Bio Co., Ltd. (177A) Shareholders
Market cap
¥4.5B
P/E ratio
40.6x
Kojin Bio manufactures bacterial culture media, antigen test kits, and cell culture products for research institutions, pharmaceutical companies, and medical facilities.
大株主
| （単位：千株） | 2024/03 | 2025/03 | 2026/03 |
|---|---|---|---|
| 中村 孝人 | 2,209.5 53.05% | 2,209.5 43.23% | 2,209.5 43.2% |
| TAKAコーポレーション | 416.5 10% | 416.5 8.15% | 416.5 8.2% |
| GOLDMAN SACHS INTERNATIONAL | 419.89 8.21% | 389.478 7.6% | |
| オリエンタル酵母工業 | 270 6.48% | 270 5.28% | 270 5.3% |
| BNY GCM CLIENT ACCOUNT JPRD AC ISG | 96.44 1.89% | 228.452 4.5% | |
| 富士フイルム和光純薬 | 140 3.36% | 140 2.74% | 140 2.7% |
| コージンバイオ従業員持株会 | 176 4.23% | 141.04 2.76% | 118.579 2.3% |
| コスモ・バイオ | 100 2.4% | 100 1.96% | 100 2% |
| 渡辺 恒美 | 120 2.88% | 107.6 2.11% | 78.9 1.5% |
| 家田化学薬品 | 72 1.41% | 72 1.4% | |
| SMBC事業開発1号投資事業有限責任組合 | 100 2.4% | ||
| 埼玉りそな銀2号投資事業組合 | 100 2.4% | ||
| ニプロ | 80 1.92% | ||
| 計 | 3,712 89.12% | 3,972.97 77.72% | 4,023.409 78.7% |